---
document_datetime: 2024-09-19 16:21:31
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/rhokiinsa-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: rhokiinsa-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.351136
conversion_datetime: 2025-12-28 14:09:40.373466
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Rhokiinsa

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                                 |
|----------------------|-----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0022               | Renewal of the marketing authorisation. | 27/06/2024                          | 06/09/2024                                  | SmPC, Annex II and PL            | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Rhokiinsa in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0021              | B.II.d.2.z - Change in test procedure for the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                           | 29/01/2024   | n/a        |                 |                                   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-----------------------------------|
| PSUSA/10781 2/202306 | Periodic Safety Update EU Single assessment - netarsudil                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 11/01/2024   | n/a        |                 | PRAC Recommendation - maintenance |
| IAIN/0019/G          | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites | 07/12/2023   | 06/09/2024 | Annex II and PL |                                   |
| IB/0017/G            | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time                                                                                                                                | 26/06/2023   | n/a        |                 |                                   |

<div style=\"page-break-after: always\"></div>

|                      | data                                                                                                                                                                                                                                                                                                                                                                                     |            |            |                  |                                   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|-----------------------------------|
| IB/0015/G            | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.1.h - Change in the specification parameters and/or limits of the finished product - Update of the dossier to comply with the provisions of an updated general monograph of the Ph. Eur. for the finished product | 14/06/2023 | n/a        |                  |                                   |
| IG/1627              | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                         | 29/05/2023 | n/a        |                  |                                   |
| IB/0014              | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                                             | 23/05/2023 | n/a        |                  |                                   |
| PSUSA/10781 2/202206 | Periodic Safety Update EU Single assessment - netarsudil                                                                                                                                                                                                                                                                                                                                 | 12/01/2023 | n/a        |                  | PRAC Recommendation - maintenance |
| N/0011               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                         | 26/07/2022 | 23/05/2023 | Labelling and PL |                                   |
| II/0010/G            | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any                                                                                                                                                                                                  | 21/07/2022 | n/a        |                  |                                   |

<div style=\"page-break-after: always\"></div>

| manufacturing operation(s) release, batch control, and sterile medicinal products aseptically manufactured) immunological medicinal B.II.b.1.b - Replacement manufacturing site for the site B.II.b.1.c - Replacement manufacturing site for the manufacturing operation(s) release/control, and secondary biol/immunol medicinal forms manufactured by processes B.II.b.1.f - Replacement manufacturing site for part manufacturing process manufacturing operation(s) release, batch control, and sterile medicinal products aseptically manufactured) immunological medicinal B.II.b.1.f - Replacement manufacturing site for part manufacturing process manufacturing operation(s) release, batch control, and sterile medicinal products aseptically manufactured) immunological medicinal   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| components or devices dossier) - Replacement B.II.e.7.b - Change in components or devices dossier) - Replacement B.II.c.1.c - Change in and/or limits of an excipient significant specification an obsolete parameter) B.II.c.1.c - Change in and/or limits of an excipient significant specification an obsolete parameter) B.II.c.1.c - Change in and/or limits of an excipient significant specification an obsolete parameter) B.II.c.1.c - Change in and/or limits of an excipient significant specification an obsolete parameter) B.II.c.1.c - Change in and/or limits of an excipient significant specification an obsolete parameter) B.II.b.2.a - Change to arrangements and quality Replacement/addition control/testing takes B.II.b.2.a - Change to arrangements and quality   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | control/testing takes place B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                  |            |            |                        |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IAIN/0009 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                             | 11/05/2022 | 23/05/2023 | Annex II and PL        |
| T/0008    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 11/01/2022 | 31/01/2022 | SmPC, Labelling and PL |
| II/0007/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 13/01/2022 | n/a        |                        |

<div style=\"page-break-after: always\"></div>

|                      | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.c.1.z - Change in immediate packaging of the AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.g - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a new manufacturer of the AS that is not supported by an ASMF and requires significant update to the relevant AS section in the dossier   |            |     |                                   |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10781 2/202106 | Periodic Safety Update EU Single assessment - netarsudil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 13/01/2022 | n/a | PRAC Recommendation - maintenance |
| PSUSA/10781 2/202012 | Periodic Safety Update EU Single assessment - netarsudil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 08/07/2021 | n/a | PRAC Recommendation - maintenance |
| IAIN/0004            | C.I.11.a - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of wording agreed by the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 28/01/2021 | n/a |                                   |
| PSUSA/10781 2/202006 | Periodic Safety Update EU Single assessment - netarsudil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 14/01/2021 | n/a | PRAC Recommendation - maintenance |
| IB/0003              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 30/11/2020 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/10781 2/201912   | Periodic Safety Update EU Single assessment - netarsudil   | 09/07/2020   | n/a   | PRAC Recommendation - maintenance   |
|------------------------|------------------------------------------------------------|--------------|-------|-------------------------------------|